Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Journal of Viral Hepatitis|December 28, 2022
A novel cDNA-uPA/SCID/Rag2-/- /Jak3-/- mouse model for hepatitis virus infection and reconstruction of human immune systemTakuro Uchida, Yuji Teraoka, Michio Imamura, et al.
Journal of Hepatology|December 15, 2010
ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivoHiromi Abe, Michio Imamura, Nobuhiko Hiraga, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 14, 2012
Morphological and microarray analyses of human hepatocytes from xenogeneic host liversChise Tateno, Fuyuki Miya, Kenjiro Wake, et al.
The Journal of General Virology|June 20, 2018
Limitations of daclatasvir/asunaprevir plus beclabuvir treatment in cases of NS5A inhibitor treatment failureYuji Teraoka, Takuro Uchida, Michio Imamura, et al.
Hepatology (Baltimore, Md.)|June 1, 2011
Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivoNobuhiko Hiraga, Michio Imamura, Hiromi Abe, et al.
Cell Reports|September 18, 2012
Generation and characterization of severe combined immunodeficiency ratsTomoji Mashimo, Akiko Takizawa, Junya Kobayashi, et al.
The Journal of Infectious Diseases|June 10, 2020
Signal Activation of Hepatitis B Virus-Related Hepatocarcinogenesis by Up-regulation of SUV39h1Yasue Takeuchi, Masataka Tsuge, Ken Tsushima, et al.
Plos One|November 5, 2015
Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA/SCID MiceChise Tateno, Yosuke Kawase, Yoshimi Tobita, et al.
Journal of Hepatology|December 15, 2010
Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric miceEiji Ohara, Nobuhiko Hiraga, Michio Imamura, et al.
Pageof 15